Today, we celebrate #NationalInternDay by recognizing the outstanding contributions of our interns and co-ops – a program total of more than 500 students representing 14 different departments! With fresh insights and unique viewpoints, AtriCure interns and co-ops create a lasting impact and play a crucial role in our success. Thank you for all you do! Looking for an internship or co-op this fall? Check out our openings at: https://okt.to/4GMnuZ #ThisisAtriCure
AtriCure, Inc.
Medical Equipment Manufacturing
Mason, Ohio 35,279 followers
We are passionately focused on healing the lives of those affected by Afib and pain after surgery.
About us
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
- Website
-
http://www.atricure.com
External link for AtriCure, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Mason, Ohio
- Type
- Public Company
- Founded
- 2000
- Specialties
- Medical Devices, Manufacturing, Atrial Fibrillation, and Maze IV Training
Locations
Employees at AtriCure, Inc.
Updates
-
AtriClip® devices have unmatched experience backed by over 15 years of clinical data that demonstrate safe and effective use. Today, it’s the most widely implanted left atrial appendage management device worldwide. Discover why: https://okt.to/Sszr9t #AtriClip #LAAE
-
For some symptomatic IST patients, medicine hasn’t proven successful. Left with limited treatment options, the HEAL-IST Trial is set out to determine the safety and effectiveness of a hybrid procedure. Do you have patients with IST who may be eligible? Visit heal-ist.com to see the qualifications. #IST #Inappropriatesinustachycardia #ClincialTrial
-
Why are innovative ergonomics important? Every heart is unique, which makes every approach to surgical ablation different. The cryoICE® probes are retractable, malleable and have an ergonomic handle. Together, these advantages enable a wide range of placement options for cardiac surgeons. Learn more: https://okt.to/Gu6oUi
-
We’re proud to share that our AtriClip® devices have received regulatory approval in China. As the most widely implanted LAAM device in the world, this expansion is a step forward in our commitment to expanding access and treatment for patients globally. Click here to read the full release: https://okt.to/ONUGb4
-
Pediatric Surgeon Dr. John DiFiore shares his experience using Cryo Nerve Block and the positive impact it has on his patients. Discover Cryo Nerve Block Therapy: https://okt.to/C0JVwH #cryoNB #PatientsFirst
-
Are you a Quality Engineer dedicated to delivering exceptional medical devices with a focus on continuous improvement? Do you have experience assisting with FDA and ISO audits and ensuring regulatory compliance? If you're passionate about quality engineering and want to make a meaningful impact, we'd love to hear from you! See our openings within our Quality Engineering team. https://okt.to/iXqSbV
-
Ischemic stroke can complicate the recovery of cardiac surgery patients. 59% of cardiac surgery patients have a high-risk of stroke even though they do not have a history of Afib. But surgical left atrial appendage exclusion may reduce the occurrence in these patients. The LeAAPS clinical trial has been designed to find out. Learn more: https://okt.to/1IU97g #ClinicalTrial #Cardiacsurgery #stroke
-
A treatment option for long-standing persistent Afib patients, EPi-Sense ST™ delivers epicardial ablations with deflection and control. To learn how EPi-Sense ST can be used to treat patients with Advanced Afib, visit: https://okt.to/u2JIwE #HybridAFTherapy #Afib #CardiacSurgery
-
Approximately 1/3 of cardiac patients have Afib but majority go undetected and untreated. Finding and treating those patients could help avoid the dysfunction caused by Afib, which leads to a 5x increased risk of developing heart failure. Visit actagainstafib.com to learn about the treatments for Afib. Source: https://bit.ly/3xyocDr